109 related articles for article (PubMed ID: 8925626)
1. Lipomas as a potential cause for uptake of In-111 MAb72.3 (Oncoscint CR).
Sakow NK; Japanwalla M; Tuckson WB; Shields RE
Clin Nucl Med; 1996 Apr; 21(4):332-3. PubMed ID: 8925626
[No Abstract] [Full Text] [Related]
2. Splenic metastasis from colon carcinoma imaged using In-111 OncoScint.
Pieslor PC; White CA; Varney RR
Clin Nucl Med; 1995 Jun; 20(6):553-4. PubMed ID: 7648747
[No Abstract] [Full Text] [Related]
3. Site of mistletoe injection observed on In-111 OncoScint imaging.
Choe W
Clin Nucl Med; 1997 Feb; 22(2):127. PubMed ID: 9031776
[No Abstract] [Full Text] [Related]
4. OncoScint image atlas.
Maguire RT
Targeted Diagn Ther; 1992; 6():141-75. PubMed ID: 1576344
[No Abstract] [Full Text] [Related]
5. Use of OncoScint scan to assess resectability of hepatic metastases from colorectal cancer.
Su WT; Brachman M; O'Connell TX
Am Surg; 2001 Dec; 67(12):1200-3. PubMed ID: 11768830
[TBL] [Abstract][Full Text] [Related]
6. OncoScint CR103 imaging in the surgical management of patients with colorectal cancer.
Doerr RJ; Abdel-Nabi HH
Targeted Diagn Ther; 1992; 6():89-109. PubMed ID: 1576352
[No Abstract] [Full Text] [Related]
7. Oncoscint for detection of disseminated colorectal and ovarian cancer.
Med Lett Drugs Ther; 1993 Jun; 35(898):52-3. PubMed ID: 8497207
[No Abstract] [Full Text] [Related]
8. 111In-CYT-103 immunoscintigraphy in ovarian cancer.
Cannistra SA
Gynecol Oncol; 1993 Nov; 51(2):292-4. PubMed ID: 8276314
[No Abstract] [Full Text] [Related]
9. Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations.
Bohdiewicz PJ; Scott GC; Juni JE; Fink-Bennett D; Wilner F; Nagle C; Dworkin HJ
Clin Nucl Med; 1995 Mar; 20(3):230-6. PubMed ID: 7750217
[TBL] [Abstract][Full Text] [Related]
10. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients.
Jusko WJ; Kung LP; Schmelter RF
Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345
[No Abstract] [Full Text] [Related]
11. In-111 pentatreotide uptake in a chondrosarcoma.
Baxter KG; Rosenthal HG; Redick ML; Preston D
Clin Nucl Med; 1996 Dec; 21(12):1008-9. PubMed ID: 8957636
[No Abstract] [Full Text] [Related]
12. [Indium 111-labeled antibodies in the detection of colorectal carcinoma].
Artiko V; Obradović V; Davidović B; Petrović N; Petrović M; Krivokapić Z; Pavlov M; Adanja G; Sobić D; Vlajković M; Pavlović S; Rebić R
Acta Chir Iugosl; 2003; 50(4):43-6. PubMed ID: 15307496
[TBL] [Abstract][Full Text] [Related]
13. Planar, SPET and three-dimensional immunoscintigraphy of suspected recurrent colorectal cancer using 111In-B72.3 (Oncoscint CR-OV): effect of administered activity.
Perkins AC; Vincent RM; Wastie ML; Denton GW; Amar S; Hardcastle JD
Nucl Med Commun; 1994 Dec; 15(12):981-90. PubMed ID: 7715898
[TBL] [Abstract][Full Text] [Related]
14. False-positive imaging of In-111 labeled monoclonal antibody conjugate CYT-103 in a patient with metastatic colorectal carcinoma.
Bhatia M; Baron PL; Alderman DF; Gordon L
Clin Nucl Med; 1995 Nov; 20(11):979-80. PubMed ID: 8565379
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunodetection of colorectal carcinoma.
Artiko V; Obradovic V; Davidovic B; Petrovic N; Petrovic M; Krivokapic Z; Kecmanovic D; Pesko P; Djukic V; Milosavljevic T; Adanja G; Vlajkovic M
Hepatogastroenterology; 2003; 50(52):1029-31. PubMed ID: 12845972
[TBL] [Abstract][Full Text] [Related]
16. [Immunoscintigraphy of prostatic cancer].
Aliaev IuG; Vinarov AZ; Rapoport LM; Bezrukov EA; Butnaru DV
Urologiia; 2006; (4):67-9. PubMed ID: 17058687
[No Abstract] [Full Text] [Related]
17. Impact of 111In-CYT-103 on the surgical management of patients with ovarian cancer.
Surwit EA
Targeted Diagn Ther; 1992; 6():125-40. PubMed ID: 1576343
[No Abstract] [Full Text] [Related]
18. A practical approach to planar and SPECT imaging of 111In-CYT-103.
Collier BD; Trembath LA; Liu Y; Turoglu HT; Patel N; Thakur S
Targeted Diagn Ther; 1992; 6():191-210. PubMed ID: 1576346
[No Abstract] [Full Text] [Related]
19. Favorable results in cancer imaging and therapy using monoclonal antibodies.
Oncology (Williston Park); 1991 Jul; 5(7):108. PubMed ID: 1837471
[No Abstract] [Full Text] [Related]
20. Radionuclide imaging of lipoma and liposarcoma.
Chew FS; Hudson TM
Radiology; 1980 Sep; 136(3):741-5. PubMed ID: 6250201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
